Drug Trial Radar · NCT05513586
A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants
Last checked: Nov 19, 2026Latest source record: May 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Sep 13, 2022
Primary completion
Oct 30, 2025
Study completion Oct 30, 2025
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Aug 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of the study is to check side effect from the study treatment with TAK-771 in long term. Participants can have taken part in the previous study TAK-771-3004 (NCT05150340). For those who can take part, the participants will receive injections of TAK-771 after the end of the previous study. The participants will be treated with TAK-771 for totally 3 years. There will be many clinic visits. The number of visits will depend on the infusion cycles of study drug.
Conditions
- Primary Immunodeficiency Diseases (PID)
Interventions
TAK-771Drug
Immune Globulin Infusion (IGI) 10% and Recombinant Human Hyaluronidase (rHuPH20)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: From start of study drug administration up to end of study (up to 3.1 years)
- Percentage of Participants Who Developed Anti-rHuPH20 Binding Antibody Titers of >=1:160 and Neutralizing Antibodies to rHuPH20Time frame: From start of study drug administration up to end of study (up to 3.1 years)
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Kyushu University Hospital
Fukuoka, Japan
Gifu University Hospital
Gifu, Japan
Hiroshima University Hospital
Hiroshima, Japan
Saitama Prefectual Children's Medical Center
Saitama, Japan
Shizuoka Childrens Hospital
Shizuoka, Japan
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Hospital of University of Occupational and Environmental Health
Kitakyushu, Fukuoka, Japan
Kanagawa Children's Medical Center
Yokohama, Kanagawa, Japan
Tokyo Medical Dental University Hospital
Bunkyo-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.